AVI Biopharma, the Bothell, WA-based developer of RNA-based therapies, said today in its quarterly financial report that it had $20.2 million in cash and investments at the end of June. The company (NASDAQ: [[ticker:AVII]]) expects to spend $10 to $12 million on operations this year, and said it anticipates it will receive more funding this … Continue reading “AVI Ends June With $20M Cash”
Do Non-Competes Curtail Startup Investments? Brownsberger and Rowe Do A Data Dive and Kick Off A Deeper Discussion
The argument over non-compete clauses in employment agreements is front and center in most discussions over ways Massachusetts can square up better against Silicon Valley. Proponents of getting rid of non-competes argue that they curtail innovation. Fearful of getting sued when they leave their employers, so the theory goes, would-be entrepreneurs either forego starting their … Continue reading “Do Non-Competes Curtail Startup Investments? Brownsberger and Rowe Do A Data Dive and Kick Off A Deeper Discussion”
Seattle Genetics Snags Milestone
Seattle Genetics, the Bothell, WA-based developer of antibody drugs for cancer, said today it has earned an undisclosed milestone payment from MedImmune, a wholly-owned subsidiary of AstraZeneca. Seattle Genetics (NASDAQ: [[ticker:SGEN]]) is due to receive the payment because MedImmune started a clinical trial with a drug that uses Seattle Genetics’ proprietary technology for making antibody … Continue reading “Seattle Genetics Snags Milestone”
Unmanned Vehicle Makers from Boston, Seattle, and San Diego (Xconomy’s Cities) Showcase Advances at DC Confab
The world’s largest collection of unmanned aircraft and other robotic systems is coming in for a landing this week in Washington, D.C., at a four-day conference that’s sponsored by AUVSI, the Association for Unmanned Vehicle Systems International. Today’s the big day for video capture, with live demonstrations of UAVs (Unmanned Aerial Vehicles) and UGVs (Unmanned … Continue reading “Unmanned Vehicle Makers from Boston, Seattle, and San Diego (Xconomy’s Cities) Showcase Advances at DC Confab”
$2.5M for Akademos
Akademos, a Norwalk, CT-based startup that sells used college textbooks and course materials through online bookstores, has raised $2.5 million in equity funding, according to documents filed August 4 with the Securities and Exhange Commission. Kohlberg Ventures of Portola Valley, CA, provided the funding, according to a press release circulated today, and Kohlberg partner Bill … Continue reading “$2.5M for Akademos”
Green Car Company Rides Wave of Plug-in Hybrids, Battery Technologies
A lot of people modify their cars, but the alterations to the hybrid Toyota Prius I was test-driving last week were more than just a fancy paint job or cool rims. In addition to the standard regenerative braking battery, I was packing an A123 Systems Hymotion L5 lithium ion battery that charged by plugging into … Continue reading “Green Car Company Rides Wave of Plug-in Hybrids, Battery Technologies”
San Diego’s Senomyx in New Lucrative Collaboration, Google Ventures is V-Vehicle Backer, KidZui Launches ZuiTube, & Other San Diego BizTech News
There were deals to report in San Diego last week. Not necessarily big deals, but even little deals are a big deal these days. Read all about it in this week’s BizTech roundup. —The V-Vehicle Co. operated in stealth mode in San Diego for three years before it surprised many in June, when the startup … Continue reading “San Diego’s Senomyx in New Lucrative Collaboration, Google Ventures is V-Vehicle Backer, KidZui Launches ZuiTube, & Other San Diego BizTech News”
Connective Orthopaedics Wants to Improve ACL Surgeries, Taps Boston Celtics CEO as Director
Sports fans know how a knee injury ruined the last season for beloved New England Patriots quarterback Tom Brady, and many other athletes before him. Now Connective Orthopaedics , a Waltham, MA, medical devices startup, is quietly researching new products that could potentially improve recoveries for people after they undergo knee surgery. Connective CEO Dean … Continue reading “Connective Orthopaedics Wants to Improve ACL Surgeries, Taps Boston Celtics CEO as Director”
Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S.
I was born and grew up in Japan and have first-hand experience as both a doctor and a patient in my native country—a nation that offers universal health care coverage to its citizens. I have also been a patient, an academic researcher and a biotech entrepreneur here in the United States, my home for the … Continue reading “Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S.”
Amgen’s Personalized Strategy for Cancer Pays Off in Big Colon Cancer Trial
Quite a few scientists at Amgen could breathe sighs of relief over the weekend—that years of their work didn’t go down the drain. The world’s biggest biotech company, which has scientific operations in Seattle and Cambridge, MA, scored a victory in its quest to make cancer drugs tailored to specific genetic subgroups, when the idea … Continue reading “Amgen’s Personalized Strategy for Cancer Pays Off in Big Colon Cancer Trial”
Imaginatik Receives $2,600,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eac96fab-f20e-4c64-9aae-1546cbdcdf48&Preview=1 Date 8/10/2009 Company Name Imaginatik Mailing Address 332 Newbury Street 2nd Floor Boston, MA 02115 Company Description Imaginatik is a software and professional services company specializing in Innovation and Idea Management as well as collaborative problem solving. For over ten years we have worked with the most demanding companies in a … Continue reading “Imaginatik Receives $2,600,000 New Financing”
Akademos Garners $2,500,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e7eb6673-1ce6-40d9-a55e-8d6bc18585e7&Preview=1 Date 8/10/2009 Company Name Akademos Mailing Address 25 Van Zant St Norwalk, CT 06855 Company Description Akademos is a operator of an online textbook exchange. Website http://www.akademos.com/ Transaction Type Venture Equity Transaction Amount $2,500,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Undisclosed
Power Assure Garners $2,500,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e25a6c75-d4ef-4092-901b-890e70127922&Preview=1 Date 8/10/2009 Company Name Power Assure Mailing Address 2394 Walsh Avenue Santa Clara, CA 95051 Company Description Power Assure develops and delivers business automation software that reduces energy use and carbon emissions in commercial, corporate, and government data centers. The company’s software platform intelligently manages data center server capacity in real … Continue reading “Power Assure Garners $2,500,000 Series A Funding Round”
Amalfi Semiconductor Garners $24,000,000 Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=74d93ce5-9ac7-41c1-b9d3-ca73bab084f6&Preview=1 Date 8/10/2009 Company Name Amalfi Semiconductor Mailing Address 475 Alberto Way Los Gatos, CA 95032 Company Description Amalfi Semiconductor is a fabless developer of high-performance CMOS RF and mixed-signal semiconductors for the cellular industry. Website http://www.amalfisemi.com/ Transaction Type Venture Equity Transaction Amount $24,000,000 Transaction Round Series C Proceeds Purposes Proceeds purposes … Continue reading “Amalfi Semiconductor Garners $24,000,000 Series C Funding Round”
Pelican Imaging Lands $7,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c9b8f901-bf49-4f2b-bf51-ea9a8fd503c7&Preview=1 Date 8/10/2009 Company Name Pelican Imaging Mailing Address 3929 Mainsail Pl Soquel, CA 95073 Company Description The company focused on commercializing computational cameras. Website http://www.pelicanimaging.com/ Transaction Type Venture Equity Transaction Amount $7,000,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Granite Ventures Venture Investor … Continue reading “Pelican Imaging Lands $7,000,000 Series A Financing”
Tempo Payments Obtains $2,700,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=efa3a62c-ab74-4d83-81b0-ead621d901ec&Preview=1 Date 8/10/2009 Company Name Tempo Payments Mailing Address 999 Baker Way San Mateo, CA 94404 Company Description Tempo provides retailers a low-cost alternative to Visa and MasterCard that delivers significant savings and revenue growth opportunities. The company operates a PIN-based payment network that uses retailer-issued and branded debit cards. Retailers issuing … Continue reading “Tempo Payments Obtains $2,700,000 New Funding”
Facebook Acquires FriendFeed for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62963648-ae67-4cd8-a1e0-d56383cc058b&Preview=1 Date 8/10/2009 Company Name FriendFeed Mailing Address 313 W. Evelyn Ave Mountain View, CA 94041 Company Description FriendFeed combines innovative technology and social solutions to make content on the web more relevant and useful. Website http://www.friendfeed.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms Financial terms of … Continue reading “Facebook Acquires FriendFeed for Undisclosed Sum”
Acquires SpringSource for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a5f3cd46-3dae-4ed6-affd-db11209eb5cf&Preview=1 Date 8/10/2009 Company Name SpringSource Mailing Address 411 Borel Avenue San Mateo, CA 94402 Company Description SpringSource is a leading provider of trusted open source software for mission-critical enterprise applications. SpringSource created and sustains the development of the Spring Framework, the leading Java™ and Java EE™ application framework. Through the Spring … Continue reading “Acquires SpringSource for Undisclosed Sum”
Microsoft Sells Razorfish to Publicis for $530M
Microsoft’s online advertising agency Razorfish has been sold to French advertising company Publicis Groupe for approximately $530 million, the French concern announced today, confirming last week’s reports that it was bidding on Razorfish. The sale had been reported before the confirmation by the Wall Street Journal and PaidContent, and perhaps by others. Publicis said in … Continue reading “Microsoft Sells Razorfish to Publicis for $530M”
Symwave Garners $4,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=97fbf3c7-aada-40e6-bffd-90719038c2dc&Preview=1 Date 8/9/2009 Company Name Symwave Mailing Address 10251 Vista Sorrento Parkway, 1st Floor San Diego, CA 92121 Company Description The company has developed a broad portfolio of analog/mixed-signal IC technology based on a high-speed, low-power, CMOS IC design that can be implemented across serial, physical and/or wireless interfaces. Website http://www.symwave.com Transaction … Continue reading “Symwave Garners $4,000,000 New Funding”
After The Crunch: The Return of Public Equity Markets
The credit crisis of 2008 and collapse of major investment banks shuttered the IPO window, and VC investments slowed to a trickle in the first half of 2009. Yet some observers are seeing strong signs of a rebound in the market and in liquidity opportunities for venture-backed startups. Connect has organized a panel of financial, … Continue reading “After The Crunch: The Return of Public Equity Markets”
Who’s Transforming the Biotech Business Model
Many companies based in San Diego are making breakthroughs and driving changes with their leading technologies. The San Diego Biotechnology Network has organized a panel and brainstorming session about who’s adapting to changing scientific and business models and how they’re doing it. Speakers include representatives from Molecular Alliance, ENRQI, Johnson & Johnson PRD, Verenium, and Anaphore. … Continue reading “Who’s Transforming the Biotech Business Model”
Merge Acquires Confirma for $22M
Bellevue, WA-based medical imaging detection software company Confirma will be acquired by Milwaukee, WI-based health IT provider Merge Healthcare for approximately $22 million, according to a press release sent out today. The acquisition will allow Merge to incorporate Confirma’s technology into its IT offerings to doctors. Confirma’s main product, CADstream, is used for prostate and … Continue reading “Merge Acquires Confirma for $22M”
Cray, InfoSpace Exceed Analyst Expectations, and Other Second-Quarter Earnings Highlights
In the past week, companies have been releasing their financial results for the second quarter. There’s a mix of good and bad news from Seattle’s public tech companies weathering the economic storm, with surprisingly positive news from some quarters. —Bellevue, WA-based metasearch developer InfoSpace announced its revenue was $43.8 million for the quarter, up 14 … Continue reading “Cray, InfoSpace Exceed Analyst Expectations, and Other Second-Quarter Earnings Highlights”
Marathon Tech Runs Down $7M
Marathon Technologies, a Littleton, MA-based provider of disaster recovery software for physical and virtual servers, has raised a $7 million round of equity financing, according to an SEC filing. A company spokesman confirmed the information in the filing, and said the company would disclose more details in the next week or so. The filing does … Continue reading “Marathon Tech Runs Down $7M”
The Shoeshine Oracles: Tech-Business Lessons from the Street
If you really want to keep your finger on the pulse of the Seattle business scene, go get your shoes shined. That’s the advice Todd Dean gave me recently. Dean is president of Keiretsu Forum Seattle/Northwest, the local chapter of the world’s largest angel investor community. He took me to see a couple of the … Continue reading “The Shoeshine Oracles: Tech-Business Lessons from the Street”
In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat
After a bruising proxy battle ousted Amylin Pharmaceuticals’ chairman and lead outside director, the San Diego biotech issued a statement on June 2 that seemed to signal a cease-fire with dissident shareholders (including Carl Icahn). “We look forward to working with all our new directors to bring transformational medicines to patients and to drive sustainable … Continue reading “In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat”
Target Leaves Amazon
Target, the Minneapolis, MN-based chain retail store announced today in a press release that it plans to build its own online store platform, ending its deal with Seattle-based Amazon.com, which has managed Target’s online sales since 2001. The current contract between the two companies extends until 2011. Target will launch its proprietary management system in … Continue reading “Target Leaves Amazon”
IPS Group, a Cellular Equipment Firm, Raising $1.5 Million in Shift to Parking Meter Business
The IPS Group, a specialized San Diego cellular technology company, is raising $1.5 million in funding from individual investors as part of a shift to the development of high-tech parking meters. The privately held company has raised more than $1.3 million so far, according to a recent filing with the Securities and Exchange Commission. The … Continue reading “IPS Group, a Cellular Equipment Firm, Raising $1.5 Million in Shift to Parking Meter Business”
Akamai And Delve Dig Into Online Video, Cardiorobotics Snags $11.6M for Snake-Like Surgery Robot, Longworth Collects $122M, & More Boston-Area Deals News
New England tech and life sciences firms forged several interesting new partnerships this week. —Apperian, a Boston-based startup developing enterprise-oriented iPhone applications, raised $1 million in a Series A venture round led by CommonAngels of Lexington, MA. —Cambridge, MA-based Akamai (NASDAQ: [[ticker:AKAM]]) teamed with Seattle’s Delve Networks to provide a new online platform for publishing … Continue reading “Akamai And Delve Dig Into Online Video, Cardiorobotics Snags $11.6M for Snake-Like Surgery Robot, Longworth Collects $122M, & More Boston-Area Deals News”
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey
Bonnie Ramsey remembers the dark days of treatment for cystic fibrosis. About 30 years ago, when she devoted her career to the research and treatment of this genetic lung disease, children who were diagnosed had a life expectancy of about 17 years. The outlook is much brighter for patients now, as quality of life has … Continue reading “Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey”
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner
[Correction appended—08/11/09] Acetylon Pharmaceuticals is unveiling its technology today after closing a $7.25 million Series A round of financing to develop novel drugs to treat multiple myeloma and rheumatoid arthritis, according to the company. Many of the startup’s backers have close ties to the Dana-Farber Cancer Institute in Boston—including the company that owns the NFL’s … Continue reading “Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner”
Marathon Technologies Corporation Receives $7,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e1d66bf1-4cb1-4154-8407-8edaeb55a99c&Preview=1 Date 8/7/2009 Company Name Marathon Technologies Corporation Mailing Address 295 Foster Street Littleton, MA 01460 Company Description Marathon’s everRun product family represents a dramatic breakthrough in application availability, moving the market past high availability and continuous availability solutions to what Marathon calls “Infinite Availability. Website http://www.marathontechnologies.com Transaction Type Venture Equity Transaction … Continue reading “Marathon Technologies Corporation Receives $7,000,000 New Financing”
Merge Technologies Incorporated Acquires Confirma for $22,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0fe2cee2-45be-42cb-ae52-d1e0fc3a3d37&Preview=1 Date 8/7/2009 Company Name Confirma Mailing Address 11040 Main Street Bellevue, WA 98004 Company Description Confirma delivers products and services that improve confidence in MRI and help practices meet the growing demand for MRI studies. CADstream® is the standard in CAD for MRI, automating the analysis and interventional guidance of MRI … Continue reading “Merge Technologies Incorporated Acquires Confirma for $22,000,000”
Atrinsic Acquires ShopIt for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b5f64259-cb71-4dc9-9416-712b6df294f6&Preview=1 Date 8/7/2009 Company Name ShopIt Mailing Address 11726 San Vicente Blvd. Los Angeles, CA 90049 Company Description Shopit is a simple to use commerce platform that enables efficient sharing and publishing of products and information anywhere online. Products and Services can be directly linked, from Shopit to any site, including popular … Continue reading “Atrinsic Acquires ShopIt for Undisclosed Sum”
Startup Day 2009
Seattle 2.0 is hosting Startup Day 2009, a conference for technologists who are thinking about founding a startup but have yet to do so. For more information about the event and to register, visit the event website.
Evening Roundtable on Funding Options
The first event in The Capital Network’s 2009-2010 Roundtable series. The program aims to present an overview of early stage capital sources from angels to VCs to grants, strategic partnership and debt financing. From the event website: “Topics will include investment criteria, time to closing, investment range, success rates, control features, compliance requirements and the … Continue reading “Evening Roundtable on Funding Options”
Looking Back, Looking Forward: A Conversation with James D. Watson and Edward O. Wilson
Presented by the Harvard Museum of Natural History as a part of the museum’s fall 2009 public lecture series, this event features Nobel Laureate James D. Watson and two-time Pulitzer Prize winner Edward O. Wilson. The pair “will reflect on their storied careers, including their time together at Harvard, and look ahead to the key … Continue reading “Looking Back, Looking Forward: A Conversation with James D. Watson and Edward O. Wilson”
Microsoft Researchers Present Next-Gen Graphics and Software Tools at SIGGRAPH
If you want to glimpse the future of gaming and entertainment software, check out the presentations at the world’s largest and most prestigious graphics conference. This week, at the annual SIGGRAPH meeting (in New Orleans this year), researchers from Microsoft and elsewhere are presenting cutting-edge techniques in computer animation, image and video processing, interactive interfaces, … Continue reading “Microsoft Researchers Present Next-Gen Graphics and Software Tools at SIGGRAPH”
Oncogenex Cash Ran Low in Q2
Bothell, WA-based Oncogenex Pharmaceuticals (NASDAQ: [[ticker:OGXI]]) announced its second fiscal quarter results today. The company reported that it had $5.7 million in cash as of the end of June, down from $12.4 million at the beginning of 2009. As Xconomy reported yesterday, Oncogenex is developing a drug to help men with prostate cancer live longer. … Continue reading “Oncogenex Cash Ran Low in Q2”
Report: Publicis Bids on Razorfish
The Wall Street Journal reported today that Publicis, a French advertising company, is at the top of the list of potential buyers for Redmond, WA-based Microsoft’s digital advertising group Razorfish in Seattle. According to the Journal’s sources, Publicis has bid between $500 million and $600 million for Razorfish, which Microsoft acquired in 2007 as part … Continue reading “Report: Publicis Bids on Razorfish”
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J
Relations appear to be increasingly strained between Biogen Idec (NASDAQ:[[ticker:BIIB]]) and the Irish drug company Elan, its partner for the distribution and development of the multiple sclerosis drug natalizumab (Tysabri). Elan said today that it has filed suit against Biogen over the Cambridge, MA-based biotech firm’s objections to Elan’s deal announced last month with affiliates … Continue reading “Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J”
Idenix to Raise $21.2 M in SPO
Idenix Pharmaceuticals (NASDAQ:[[ticker:IDIX]]), a Cambridge, MA-based developer of anti-viral drugs, announced today in a press release that it has priced a secondary public offering of 7.25 million shares at $3.14 each. Idenix expects to raise $21.2 million from the offer, which is expected to close on August 10, after processing fees and other costs. The … Continue reading “Idenix to Raise $21.2 M in SPO”
Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement
Stephen Friend had it all at Merck. The lucrative salary, the national media fame, the respect of peers, the power to snap his fingers and command a corporate army of some of the brightest minds in biomedicine. This year, he gave it all up for a startup dream. Friend, 54, is best known in Seattle … Continue reading “Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement”
Ichor Gets $3.3M Alzheimer’s Grant
Ichor Medical Systems, a privately held San Diego biotech, says it’s getting a $3.3 million grant award from the National Institute of Neurological Disorders and Stroke to develop a vaccine for Alzheimer’s disease. Using an electroporation delivery system that creates temporary pores in cell membranes, Ichor has been developing DNA vaccines and drugs for treating … Continue reading “Ichor Gets $3.3M Alzheimer’s Grant”
Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body
(Updated: 1:20 pm ET with new commentary from Alnylam’s CEO.) Alnylam Pharmaceuticals and Tekmira Pharmaceuticals announced today that they have teamed up to develop new particles to deliver RNA-interference drugs. Their joint effort aims to identify new ways to overcome the hurdles that the gene-modulating drugs must clear to reach diseased cells deep in the … Continue reading “Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body”
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News
It might be the dog days of summer, but San Diego’s life sciences companies kept up a busy flow of cool news over the past week. Get your update here. —Isis Pharmaceuticals, the Carlsbad, CA, biotech that specializes in so-called antisense technology, is getting ready to test a new treatment later this year for patients … Continue reading “Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News”
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
Some of the lesser-known names in Seattle life sciences made some noise this week, just when we here at the Xconomy biotech desk thought things might slow down a tad in the dog days of summer. —AVI Biopharma (NASDAQ: [[ticker:AVII]]), the Portland, OR-based maker of RNA-based therapies, is now getting a new tagline as the … Continue reading “AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News”
Protecting America’s Leadership in Biotech Discovery
Health care reform took a turn for the better when members of key committees in both the U.S. Senate and House of Representatives recently recommended an approval pathway for biosimilars—products that attempt to be similar to an innovator biologic drug—while also preserving the hope for future medical treatments. Specifically, the committees agreed that to preserve … Continue reading “Protecting America’s Leadership in Biotech Discovery”
Cardiorobotics, Developer of Snake Robot Technology, Aims to Alter Cardiac Surgery
The future of heart surgery is in something called a “snake robot,” at least according to the people at Newport, RI-based Cardiorobotics. We decided to check it out in more depth since Cardiorobotics just raised $11.6 million this week to see if it can demonstrate this is truly the next frontier in minimally invasive ways … Continue reading “Cardiorobotics, Developer of Snake Robot Technology, Aims to Alter Cardiac Surgery”